The impact of COVID-19 on ophthalmology practice in Egypt

Mahmoud, Hala R.

doi:10.4102/aveh.v79i1.604

Cited by 2 publications

(2 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…23 Unfortunately, we lack the essential infrastructure and clear laws regulating the application of telemedicine in the Nile Delta region. 15 It is vital to train orthoptists in the rural and the suburban areas to regularly check patients' I. O.P., do visual fields and fundus photography and send them to the responsible ophthalmologists in the tertiary care hospitals.…”

Section: Discussionmentioning

confidence: 99%

Influence of COVID‑19 on the Prognosis and Medication Compliance of Glaucoma Patients in the Nile Delta Region

Awwad¹,

Masoud²

2021

OPTH

View full text Add to dashboard Cite

Objective: To assess the influence of the COVID-19 pandemic on the medication adherence and follow-up of glaucoma patients in the Nile Delta region. Setting: A tertiary care center in the Nile Delta region, Egypt. Study Design: An observational, cross-sectional study. Participants: Patients' records (2019-2020; group A) and (2020-2021; group B) were assessed for missed follow-up visits, medication adherence, number of trabeculectomies performed, and uncontrolled patients. In addition, a telephone-based questionnaire involving randomly chosen 200 patients from B.G.U. was carried out to clarify the potential causes of poor patients' compliance. Results: There was a marked decline in the number of newly diagnosed patients and patients on regular follow-up with incidence rates 0.208 and 0.088 in group (A) and group (B), respectively (P-value < 0.0001). The number of compliant patients in group B decreased with an incidence rate difference of 0.312. The number of trabeculectomies declined in group (B) with an incidence rate in group (A) 0.131 compared to 0.081 in group (B). On the other hand, the number of uncontrolled glaucoma patients increased in group B with an incidence rate difference −0.231 between the two groups. 21.5% of patients who participated in the questionnaire identified financial issues as the leading cause of non-compliance. Comorbidities (19.5%), lockdown and transportation difficulties were also highlighted. Conclusion: COVID-19 had greatly hampered glaucoma care in the Nile Delta region. As a result, we need to implement new technologies like telemedicine and improve patients' awareness of glaucoma care. Training orthoptists and using mobile glaucoma care services would also be helpful ways of managing glaucoma during that pandemic.

show abstract

Section: Discussionmentioning

confidence: 99%

Influence of COVID‑19 on the Prognosis and Medication Compliance of Glaucoma Patients in the Nile Delta Region

Awwad¹,

Masoud²

2021

OPTH

View full text Add to dashboard Cite

show abstract

“…Regular and thorough monitoring is essential for this potentially blinding condition. The new WHO regulations to combat COVID-19 had a significant impact on the follow-up appointments of glaucoma patients ( 53 , 58 ). The scheduled postoperative follow-up visits were decreased by 43.9% ( 59 ).…”

Section: Impact Of Covid-19 On Glaucoma Treatment Follow-up and Medic...mentioning

confidence: 99%

Impact of COVID-19 on glaucoma management: A review

Yadav

Tanwar²

2022

Front. Ophthalmol.

View full text Add to dashboard Cite

Glaucoma is the leading cause of irreversible vision loss and the second leading cause of blindness worldwide. The rapid transmission of SARS-CoV-2virus compelled governments to concentrate their efforts on emergency units to treat the large number of cases that arose due to the Covid-19 outbreak. As a result, many chronically ill patients were left without access to medical care. The progression of glaucoma in previously diagnosed cases has been accelerated; due to this, some have lost their vision. Evaluation of Covid-19’s effect on glaucoma treatment was one goal of this study. We used search phrases like “COVID-19,” “telemedicine,” and “glaucoma” to find published papers on COVID-19 and glaucoma. Artificial Intelligence (AI) may be the answer to the unanswered questions that arose due to this pandemic crisis. The benefits and drawbacks of AI in the context of teliglaucoma have been thoroughly examined. These AI-related ideas have been floating around for some time. We hope that Covid-19’s enormous revisions will provide them with the motivation to move forward and significantly improve services. Despite the devastation the pandemic has caused, we are hopeful that eye care services will be better prepared and better equipped to avoid the loss of sight due to glaucoma in future.

show abstract

The impact of COVID-19 on ophthalmology practice in Egypt

Cited by 2 publications

References 10 publications

Influence of COVID‑19 on the Prognosis and Medication Compliance of Glaucoma Patients in the Nile Delta Region

Influence of COVID‑19 on the Prognosis and Medication Compliance of Glaucoma Patients in the Nile Delta Region

Impact of COVID-19 on glaucoma management: A review

Contact Info

Product

Resources

About